openPR Logo
Press release

Lawsuit filed for Investors in shares of Frequency Therapeutics, Inc. (NASDAQ: FREQ)

06-09-2021 10:46 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Frequency Therapeutics, Inc. (NASDAQ: FREQ) shares.

A lawsuit was filed on behalf of investors in Frequency Therapeutics, Inc. (NASDAQ: FREQ) shares.

An investor, who purchased shares of Frequency Therapeutics, Inc. (NASDAQ: FREQ), filed a lawsuit over alleged violations of Federal Securities Laws by Frequency Therapeutics, Inc.

Investors who purchased shares of Frequency Therapeutics, Inc. (NASDAQ: FREQ) have certain options and for certain investors are short and strict deadlines running. Deadline: August 2, 2021. NASDAQ: FREQ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Woburn, MA based Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases.
On or around October 2, 2019, Frequency Therapeutics, Inc conducted its initial public offering ("IPO"), selling 6,000,000 shares of common stock priced at $14.00 per share.
Frequency Therapeutics, Inc. began its Phase 2a trial for FX-322 in October 2019. The trial results failed to live up to the Company’s expectations, as they revealed no discernable difference between FX-322 and the placebo. However, the Company continued to conduct the trial and released positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322’s potential.
During this period, CEO David Lucchino sold over 350,000 shares valued near $9 million in the months prior to releasing the results of the Phase 2a trial.

On March 23, 2021, Frequency announced the topline, day-90 data from its FX-322 Phase 2a study (FX-322-202). Frequency Therapeutics, Inc disclosed that "[t]he interim results show that four weekly injections in subjects with mild to moderately severe sensorineural hearing loss (SNHL) did not demonstrate improvements in hearing measures versus placebo."

Shares of Frequency Therapeutics, Inc. (NASDAQ: FREQ) declined to as low as $7.34 per share on March 30, 2021.

The plaintiff claims that between November 16, 2020, and March 22, 2021, the defendants made false and/or misleading statements and/or failed to disclose that Frequency's development and commercialization of a hearing loss treatment titled "FX-322" was not producing the results Frequency desired, that FX-322's ongoing clinical study was not as positive as Frequency portrayed, and that as a result of the foregoing, defendants' positive statements about Frequency's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Frequency Therapeutics, Inc. (NASDAQ: FREQ) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors in shares of Frequency Therapeutics, Inc. (NASDAQ: FREQ) here

News-ID: 2301951 • Views: 717

More Releases from Shareholders Foundation

Investigation for Investors in San Juan Basin Royalty Trust (NYSE: SJT) announce …
An investigation on behalf of current long-term investors in shares of San Juan Basin Royalty Trust (NYSE: SJT) was announced over potential breaches of fiduciary duties. Investors who purchased shares of San Juan Basin Royalty Trust (NYSE: SJT) and currently hold any of those San Juan Basin Royalty Trust (NYSE: SJT shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by
Investigation announced for Investors in China Evergrande Group (EGRNY, EGRNF)
An investigation on behalf of investors of China Evergrande Group (EGRNY, EGRNF) shares over potential securities laws violations by China Evergrande Group and certain of its directors and officers in connection with certain financial statements was announced. Investors who purchased shares of China Evergrande Group (EGRNY, EGRNF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on
Investigation for Long-Term Investors in shares of Rekor Systems, Inc. (NASDAQ: …
An investigation on behalf of current long-term investors in shares of Rekor Systems, Inc. (NASDAQ: REKR) concerning potential breaches of fiduciary duties by certain directors and officers of Rekor Systems, Inc. was announced. Investors who are current long term investors in Rekor Systems, Inc. (NASDAQ: REKR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for
Advance Auto Parts, Inc. (NYSE: AAP) Investor Alert: Update in Lawsuit against A …
The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of Advance Auto Parts, Inc. (NYSE: AAP). Investors who purchased shares of Advance Auto Parts, Inc. (NYSE: AAP), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On February 06, 2018, a lawsuit was filed against Advance Auto Parts, Inc. (NYSE: AAP) over alleged violations of Federal

All 5 Releases


More Releases for Frequency

High Frequency Welded (HFW) Pipe
The straight seam high frequency welded (HFW) pipe has the characteristics of simple production process and fast continuous production. It has a wide range of uses in civil construction, petrochemical, light industry and other fields. It is mainly used to transport low-pressure fluids or manufacture components and light industrial products for various projects. High-frequency welding is a kind of induction welding (or pressure contact welding). It does not require welding seam
Radio Frequency Beauty Equipment Market
Radio Frequency Beauty Equipment refers to radio frequency waves that heat the tissues and stimulates the remodeling and production of elastin and novel collagen. These are devised for treating common skin aging issues like wrinkles, excessive fat tissues or cellulites. The Radio Frequency Beauty Equipment market is anticipated to grow in the forecast, owing to the factors such as increasing demand for radiofrequency beauty procedures, rising prevalence of skin problems leading
Frequency Converter Market
Frequency Converter Global Market – Overview A frequency converter is an electronic or electromechanical device that converts the frequency of alternating current according to the requirement of the appliance connected. It is used to manage the speed of a pump with frequency inverter. Furthermore, these converters can minimize the electrical and mechanical stress. A frequency converter plays an important role, in extending the durability of the motors, pumps and other equipment.
Global and Japan Isolation Transformers Market, 2017 To 2022: By Frequency - Low …
Researchmoz added Most up-to-date research on "Global and Japan Isolation Transformers Market, 2017 To 2022: By Frequency - Low Frequency, Intermediate Frequency & High Frequency" to its huge collection of research reports. The global Isolation Transformers market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022. Japan plays an important
Global Radio Frequency (RF) Market: by Types - Low Frequency, IF, High Frequency
Latest industry research report on: Global Radio Frequency (RF) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Request For Sample Report @ http://www.marketresearchreports.biz/sample/sample/1055693 This report studies the global Radio Frequency (RF) market, analyzes and researches the Radio Frequency (RF) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Murata Radiall Amphenol AVX TE Taoglas Switchcraft Pomona Hirose Electric Neutrik Molex Cinch Connectivity
easyJet Ups Flight Frequency to Gibraltar
This week low-cost airline easyJet strengthened its commitment to Gibraltar by adding four extra weekly flights to its London Gatwick service. Scheduled to begin next summer, the airline will now operate 11 flights a week to this London airport. Brian Stevendale, Business and Development Director for Gibraltar’s most prominent mixed-use marina resort, Ocean Village, says, “This move by easyJet makes good sense as Gibraltar rises in stature as a destination